{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:33:54Z","timestamp":1787585634501,"version":"build-2736575974"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11596-026-00230-8","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:28:18Z","timestamp":1785317298000},"page":"946-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KLF4 in Parkinson\u2019s Disease: Decoding the Molecular Puzzle of Neuroinflammation, Oxidative Stress, and Emerging Therapies"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8903-3202","authenticated-orcid":false,"given":"Anjali","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"3","key":"230_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM. Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci. 2023;10(3):200\u2013231.","journal-title":"AIMS Neurosci."},{"issue":"10291","key":"230_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u20132303.","journal-title":"Lancet."},{"issue":"2","key":"230_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/cells10020375","volume":"10","author":"IC Br\u00e1s","year":"2021","unstructured":"Br\u00e1s IC, Outeiro TF. Alpha-synuclein: mechanisms of release and pathology progression in synucleinopathies. Cells. 2021;10(2):375.","journal-title":"Cells."},{"key":"230_CR4","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson DW. Neuropathology of Parkinson disease. Park Relat Disord. 2018;46:S30\u2013S33.","journal-title":"Park Relat Disord."},{"issue":"2","key":"230_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.14802\/jmd.15003","volume":"8","author":"HM Lee","year":"2015","unstructured":"Lee HM, Koh SB. Many faces of Parkinson\u2019s disease: non-motor symptoms of Parkinson\u2019s disease. JMD. 2015;8(2):92\u201397.","journal-title":"JMD."},{"issue":"4","key":"230_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40263-013-0053-2","volume":"27","author":"F Sprenger","year":"2013","unstructured":"Sprenger F, Poewe W. Management of motor and non-motor symptoms in Parkinson\u2019s disease. CNS Drugs. 2013;27(4):259\u2013272.","journal-title":"CNS Drugs."},{"issue":"5","key":"230_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.4103\/ijcm.ijcm_972_22","volume":"48","author":"M Arun","year":"2023","unstructured":"Arun M, Thomas PT, Kamble NL, et al. Disability certification for Parkinson\u2019s disease in India: challenges and the way forward. Indian J Community Med. 2023;48(5):639\u2013640.","journal-title":"Indian J Community Med."},{"issue":"22","key":"230_CR8","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1182\/blood-2010-05-285353","volume":"116","author":"Z Cao","year":"2010","unstructured":"Cao Z, Sun X, Icli B, et al. Role of Kr\u00fcppel-like factors in leukocyte development, function, and disease. Blood. 2010;116(22):4404\u20134414.","journal-title":"Blood."},{"issue":"21","key":"230_CR9","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1128\/MCB.00838-12","volume":"32","author":"S Qin","year":"2012","unstructured":"Qin S, Zhang CL. Role of Kruppel-like factor 4 in neurogenesis and radial neuronal migration in the developing cerebral cortex. Mol Cell Biol. 2012;32(21):4297\u20134305.","journal-title":"Mol Cell Biol."},{"issue":"52","key":"230_CR10","doi-asserted-by":"publisher","first-page":"21117","DOI":"10.1073\/pnas.1112351109","volume":"108","author":"S Qin","year":"2011","unstructured":"Qin S, Liu M, Niu W, et al. Dysregulation of Kruppel-like factor 4 during brain development leads to hydrocephalus in mice. Proc Natl Acad Sci U S A. 2011;108(52):21117\u201321121.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"230_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1515\/biol-2020-0069","volume":"15","author":"J Liu","year":"2020","unstructured":"Liu J, Liu D, Zhao B, et al. Long non-coding RNA NEAT1 mediates MPTP\/MPP+-induced apoptosis via regulating the miR-124\/KLF4 axis in Parkinson\u2019s disease. Open Life Sci. 2020;15(1):665\u2013676.","journal-title":"Open Life Sci."},{"issue":"5","key":"230_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188801","volume":"1877","author":"AI Giannopoulou","year":"2022","unstructured":"Giannopoulou AI, Kanakoglou DS, Papavassiliou AG, et al. Insights into the multi-faceted role of Pioneer transcription factors in glioma formation and progression with targeting options. Biochim Biophys Acta Rev Cancer. 2022;1877(5):188801.","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"230_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.gene.2017.02.025","volume":"611","author":"AM Ghaleb","year":"2017","unstructured":"Ghaleb AM, Yang VW. Kr\u00fcppel-like factor 4 (KLF4): what we currently know. Gene. 2017;611:27\u201337.","journal-title":"Gene."},{"issue":"37","key":"230_CR14","doi-asserted-by":"publisher","first-page":"60290","DOI":"10.18632\/oncotarget.11200","volume":"7","author":"Q Xu","year":"2016","unstructured":"Xu Q, Liu M, Zhang J, et al. Overexpression of KLF4 promotes cell senescence through microRNA-203-survivin-p21 pathway. Oncotarget. 2016;7(37):60290\u201360302.","journal-title":"Oncotarget."},{"issue":"10","key":"230_CR15","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00018-008-7552-1","volume":"65","author":"I D\u2019Errico","year":"2008","unstructured":"D\u2019Errico I, Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell Mol Life Sci. 2008;65(10):1523\u20131543.","journal-title":"Cell Mol Life Sci."},{"key":"230_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fncel.2018.00325","volume":"12","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, Zou X, Jin Y, et al. The role of KLF4 in Alzheimer\u2019s disease. Front Cell Neurosci. 2018;12:325.","journal-title":"Front Cell Neurosci."},{"issue":"6","key":"230_CR17","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1007\/s12035-023-03800-2","volume":"61","author":"MY Zamanian","year":"2024","unstructured":"Zamanian MY, Golmohammadi M, Amin RS, et al. Therapeutic targeting of Kr\u00fcppel-like factor 4 and its pharmacological potential in Parkinson\u2019s disease: a comprehensive review. Mol Neurobiol. 2024;61(6):3596\u20133606.","journal-title":"Mol Neurobiol."},{"key":"230_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41531-021-00179-6","volume":"7","author":"KM Miller","year":"2021","unstructured":"Miller KM, Mercado NM, Sortwell CE. Synucleinopathy-associated pathogenesis in Parkinson\u2019s disease and the potential for brain-derived neurotrophic factor. NPJ Parkinsons Dis. 2021;7:35.","journal-title":"NPJ Parkinsons Dis."},{"issue":"5","key":"230_CR19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/ame2.70015","volume":"8","author":"Z Wei","year":"2025","unstructured":"Wei Z, Liu C, Chen J, et al. Kr\u00fcppel-like factor 4 transcription factor in blood\u2013brain barrier endothelial cells: a potential role in Alzheimer\u2019s disease. Anim Models Exp Med. 2025;8(5):819\u2013828.","journal-title":"Anim Models Exp Med."},{"issue":"1","key":"230_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12920-020-00822-w","volume":"13","author":"J Cheng","year":"2020","unstructured":"Cheng J, Liu HP, Lin WY, et al. Identification of contributing genes of Huntington\u2019s disease by machine learning. BMC Med Genomics. 2020;13(1):176.","journal-title":"BMC Med Genomics."},{"key":"230_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","volume":"86","author":"H Sies","year":"2017","unstructured":"Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem. 2017;86:715\u2013748.","journal-title":"Annu Rev Biochem."},{"issue":"9","key":"230_CR22","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.3390\/ijms24097898","volume":"24","author":"SK Masenga","year":"2023","unstructured":"Masenga SK, Kabwe LS, Chakulya M, et al. Mechanisms of oxidative stress in metabolic syndrome. IJMS. 2023;24(9):7898.","journal-title":"IJMS."},{"key":"230_CR23","doi-asserted-by":"crossref","unstructured":"Segura-Aguilar J, Paris I. Mechanisms of dopamine oxidation and Parkinson\u2019s disease. Handbook of Neurotoxicity. Cham: Springer, 2021:1\u201336.","DOI":"10.1007\/978-3-030-71519-9_16-1"},{"key":"230_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.858142","volume":"9","author":"ER Gansemer","year":"2022","unstructured":"Gansemer ER, Rutkowski DT. Pathways linking nicotinamide adenine dinucleotide phosphate production to endoplasmic reticulum protein oxidation and stress. Front Mol Biosci. 2022;9:858142.","journal-title":"Front Mol Biosci."},{"issue":"7","key":"230_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/antiox9070597","volume":"9","author":"KH Chang","year":"2020","unstructured":"Chang KH, Chen CM. The role of oxidative stress in Parkinson\u2019s disease. Antioxidants. 2020;9(7):597.","journal-title":"Antioxidants."},{"issue":"6","key":"230_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s13760-020-01473-5","volume":"120","author":"A Cherian","year":"2020","unstructured":"Cherian A, Divya KP. Genetics of Parkinson\u2019s disease. Acta Neurol Belg. 2020;120(6):1297\u20131305.","journal-title":"Acta Neurol Belg."},{"issue":"1","key":"230_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12031-013-9961-3","volume":"51","author":"J Chen","year":"2013","unstructured":"Chen J, Wang X, Yi X, et al. Induction of KLF4 contributes to the neurotoxicity of MPP+ in M17 cells: a new implication in Parkinson\u2019s disease. J Mol Neurosci. 2013;51(1):109\u2013117.","journal-title":"J Mol Neurosci."},{"issue":"4","key":"230_CR28","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1007\/s11357-014-9685-5","volume":"36","author":"C Su","year":"2014","unstructured":"Su C, Sun F, Cunningham RL, et al. ERK5\/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning. Age (Dordr). 2014;36(4):9685.","journal-title":"Age (Dordr)."},{"issue":"2","key":"230_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","volume":"154","author":"J Stephenson","year":"2018","unstructured":"Stephenson J, Nutma E, van der Valk P, et al. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154(2):204\u2013219.","journal-title":"Immunology."},{"key":"230_CR30","doi-asserted-by":"publisher","first-page":"9999146","DOI":"10.1155\/2021\/9999146","volume":"2021","author":"R K\u00f6lliker-Frers","year":"2021","unstructured":"K\u00f6lliker-Frers R, Udovin L, Otero-Losada M, et al. Neuroinflammation: an integrating overview of reactive-neuroimmune cell interactions in health and disease. Mediators Inflamm. 2021;2021:9999146.","journal-title":"Mediators Inflamm."},{"issue":"5","key":"230_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1734-1140(10)70338-8","volume":"62","author":"J D\u0105bek","year":"2010","unstructured":"D\u0105bek J, Ku\u0142ach A, G\u0105sior Z. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB): a new potential therapeutic target in atherosclerosis? Pharmacol Rep. 2010;62(5):778\u2013783.","journal-title":"Pharmacol Rep."},{"issue":"3","key":"230_CR32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.14336\/AD.2018.0513","volume":"10","author":"W Tu","year":"2019","unstructured":"Tu W, Wang H, Li S, et al. The anti-inflammatory and anti-oxidant mechanisms of the Keap1\/Nrf2\/ARE signaling pathway in chronic diseases. Aging Dis. 2019;10(3):637\u2013651.","journal-title":"Aging Dis."},{"issue":"3","key":"230_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41583-020-0263-9","volume":"21","author":"AD Greenhalgh","year":"2020","unstructured":"Greenhalgh AD, David S, Bennett FC. Immune cell regulation of glia during CNS injury and disease. Nat Rev Neurosci. 2020;21(3):139\u2013152.","journal-title":"Nat Rev Neurosci."},{"key":"230_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1742-2094-7-68","volume":"7","author":"DK Kaushik","year":"2010","unstructured":"Kaushik DK, Gupta M, Das S, et al. Kr\u00fcppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation. J Neuroinflammation. 2010;7:68.","journal-title":"J Neuroinflammation."},{"issue":"2","key":"230_CR35","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"53","author":"Y Tang","year":"2016","unstructured":"Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol. 2016;53(2):1181\u20131194.","journal-title":"Mol Neurobiol."},{"key":"230_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neuroscience.2022.01.014","volume":"488","author":"Z You","year":"2022","unstructured":"You Z, Yang Z, Cao S, et al. The novel KLF4\/BIG1 regulates LPS-mediated neuro-inflammation and migration in BV2 cells via PI3K\/Akt\/NF-kB signaling pathway. Neuroscience. 2022;488:102\u2013111.","journal-title":"Neuroscience."},{"key":"230_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109191","volume":"112","author":"NK El-Deeb","year":"2022","unstructured":"El-Deeb NK, El-Tanbouly DM, Khattab MA, et al. Crosstalk between PI3K\/AKT\/KLF4 signaling and microglia M1\/M2 polarization as a novel mechanistic approach towards flibanserin repositioning in Parkinson\u2019s disease. Int Immunopharmacol. 2022;112:109191.","journal-title":"Int Immunopharmacol."},{"key":"230_CR38","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fnins.2020.00930","volume":"14","author":"S Zhou","year":"2020","unstructured":"Zhou S, Zhang D, Guo J, et al. Knockdown of SNHG14 alleviates MPP+-induced injury in the cell model of Parkinson\u2019s disease by targeting the miR-214-3p\/KLF4 axis. Front Neurosci. 2020;14:930.","journal-title":"Front Neurosci."},{"issue":"4","key":"230_CR39","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.62347\/MIHM9413","volume":"17","author":"S Velez","year":"2025","unstructured":"Velez S. Implications of Kr\u00fcppel-like factor signaling in neuroinflammation for neurodegenerative diseases. Am J Transl Res. 2025;17(4):3009\u20133030.","journal-title":"Am J Transl Res."},{"issue":"1","key":"230_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41420-023-01416-y","volume":"9","author":"Z He","year":"2023","unstructured":"He Z, He J, Xie K. KLF4 transcription factor in tumorigenesis. Cell Death Discov. 2023;9(1):118.","journal-title":"Cell Death Discov."},{"issue":"1","key":"230_CR41","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.bbrc.2009.12.002","volume":"391","author":"G Villarreal","year":"2010","unstructured":"Villarreal G, Zhang Y, Larman HB, et al. Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells. Biochem Biophys Res Commun. 2010;391(1):984\u2013989.","journal-title":"Biochem Biophys Res Commun."},{"issue":"6","key":"230_CR42","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1053\/j.gastro.2010.08.022","volume":"139","author":"D Wei","year":"2010","unstructured":"Wei D, Wang L, Kanai M, et al. KLF4\u03b1 up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology. 2010;139(6):2135\u20132145.","journal-title":"Gastroenterology."},{"key":"230_CR43","doi-asserted-by":"crossref","unstructured":"Simcox EM, Reeve AK. An introduction to mitochondria, their structure and functions. Mitochondrial Dysfunction in Neurodegenerative Disorders. Cham: Springer, 2016:3\u201330.","DOI":"10.1007\/978-3-319-28637-2_1"},{"issue":"s1","key":"230_CR44","doi-asserted-by":"publisher","first-page":"S399","DOI":"10.3233\/JAD-220682","volume":"94","author":"P Naren","year":"2023","unstructured":"Naren P, Cholkar A, Kamble S, et al. Pathological and therapeutic advances in Parkinson\u2019s disease: mitochondria in the interplay. J Alzheimers Dis. 2023;94(s1):S399\u2013S428.","journal-title":"J Alzheimers Dis."},{"key":"230_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020;37:101674.","journal-title":"Redox Biol."},{"key":"230_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.612476","volume":"9","author":"W Li","year":"2021","unstructured":"Li W, Fu Y, Halliday GM, et al. PARK genes link mitochondrial dysfunction and alpha-synuclein pathology in sporadic Parkinson\u2019s disease. Front Cell Dev Biol. 2021;9:612476.","journal-title":"Front Cell Dev Biol."},{"key":"230_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102784","volume":"56","author":"SL Stenton","year":"2020","unstructured":"Stenton SL, Prokisch H. Genetics of mitochondrial diseases: Identifying mutations to help diagnosis. EBioMedicine. 2020;56:102784.","journal-title":"EBioMedicine."},{"issue":"9","key":"230_CR48","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1172\/JCI79964","volume":"125","author":"X Liao","year":"2015","unstructured":"Liao X, Zhang R, Lu Y, et al. Kruppel-like factor 4 is critical for transcriptional control of cardiac mitochondrial homeostasis. J Clin Investig. 2015;125(9):3461\u20133476.","journal-title":"J Clin Investig."},{"issue":"9","key":"230_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4172\/2157-7633.1000436","volume":"8","author":"B Tung","year":"2018","unstructured":"Tung B, Xia S. Kruppel-like factor 4 (KLF4) and its regulation on mitochondrial homeostasis. J Stem Cell Res Ther. 2018;8(9):436.","journal-title":"J Stem Cell Res Ther."},{"issue":"2","key":"230_CR50","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12035-013-8554-z","volume":"49","author":"G Anderson","year":"2014","unstructured":"Anderson G, Maes M. Neurodegeneration in Parkinson\u2019s disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol Neurobiol. 2014;49(2):771\u2013783.","journal-title":"Mol Neurobiol."},{"issue":"5","key":"230_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/138920309789351921","volume":"10","author":"VN Uversky","year":"2009","unstructured":"Uversky VN, Eliezer D. Biophysics of Parkinson\u2019s disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci. 2009;10(5):483\u2013499.","journal-title":"Curr Protein Pept Sci."},{"key":"230_CR52","doi-asserted-by":"crossref","unstructured":"Thanaskody K, Jusop AS, Tye GJ, et al. MSCs vs. iPSCs: Potential in therapeutic applications. Front Cell Dev Biol. 2022;10:1005926.","DOI":"10.3389\/fcell.2022.1005926"},{"issue":"4","key":"230_CR53","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/cells10040830","volume":"10","author":"A Blum","year":"2021","unstructured":"Blum A, Mostow K, Jackett K, et al. KLF4 regulates metabolic homeostasis in response to stress. Cells. 2021;10(4):830.","journal-title":"Cells."},{"issue":"2","key":"230_CR54","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s12035-016-9743-3","volume":"54","author":"J Zhao","year":"2017","unstructured":"Zhao J, Yu S, Zheng Y, et al. Oxidative modification and its implications for the neurodegeneration of Parkinson\u2019s disease. Mol Neurobiol. 2017;54(2):1404\u20131418.","journal-title":"Mol Neurobiol."},{"issue":"15","key":"230_CR55","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.3390\/ijms22158338","volume":"22","author":"A Jan","year":"2021","unstructured":"Jan A, Gon\u00e7alves NP, Vaegter CB, et al. The prion-like spreading of alpha-synuclein in Parkinson\u2019s disease: update on models and hypotheses. IJMS. 2021;22(15):8338.","journal-title":"IJMS."},{"issue":"5","key":"230_CR56","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/antiox13050606","volume":"13","author":"MI Prasanth","year":"2024","unstructured":"Prasanth MI, Sivamaruthi BS, Cheong CSY, et al. Role of epigenetic modulation in neurodegenerative diseases: implications of phytochemical interventions. Antioxidants (Basel). 2024;13(5):606.","journal-title":"Antioxidants (Basel)."},{"key":"230_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-022-00524-0","volume":"17","author":"LK Wareham","year":"2022","unstructured":"Wareham LK, Liddelow SA, Temple S, et al. Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol Neurodegeneration. 2022;17:23.","journal-title":"Mol Neurodegeneration."},{"issue":"4","key":"230_CR58","doi-asserted-by":"publisher","first-page":"946","DOI":"10.14336\/AD.2019.0923","volume":"11","author":"C Joseph","year":"2020","unstructured":"Joseph C, Mangani AS, Gupta V, et al. Cell cycle deficits in neurodegenerative disorders: uncovering molecular mechanisms to drive innovative therapeutic development. Aging Dis. 2020;11(4):946\u2013966.","journal-title":"Aging Dis."},{"key":"230_CR59","doi-asserted-by":"crossref","unstructured":"Prabhu SR. Cell injury: causes, mechanisms and responses. Pathological Basis of Oral and Maxillofacial Diseases. Hoboken, NJ United States: John Wiley & Sons; 2024:64\u201381.","DOI":"10.1002\/9781119989233.ch6"},{"issue":"4","key":"230_CR60","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/fcp.12767","volume":"36","author":"B Hakiminia","year":"2022","unstructured":"Hakiminia B, Alikiaii B, Khorvash F, et al. Oxidative stress and mitochondrial dysfunction following traumatic brain injury: From mechanistic view to targeted therapeutic opportunities. Fundam Clin Pharmacol. 2022;36(4):612\u2013662.","journal-title":"Fundam Clin Pharmacol."},{"issue":"7","key":"230_CR61","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s11010-023-04870-5","volume":"479","author":"N Ghorbani","year":"2024","unstructured":"Ghorbani N, Yaghubi R, Davoodi J, et al. How does caspases regulation play role in cell decisions? apoptosis and beyond. Mol Cell Biochem. 2024;479(7):1599\u20131613.","journal-title":"Mol Cell Biochem."},{"key":"230_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.985363","volume":"12","author":"S Qian","year":"2022","unstructured":"Qian S, Wei Z, Yang W, et al. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022;12:985363.","journal-title":"Front Oncol."},{"issue":"7","key":"230_CR63","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.1007\/s13277-016-5035-9","volume":"37","author":"Y Kiraz","year":"2016","unstructured":"Kiraz Y, Adan A, Kartal Yandim M, et al. Major apoptotic mechanisms and genes involved in apoptosis. Tumour Biol. 2016;37(7):8471\u20138486.","journal-title":"Tumour Biol."},{"key":"230_CR64","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fncel.2019.00507","volume":"13","author":"Y Hua","year":"2019","unstructured":"Hua Y, Yang B, Chen Q, et al. Activation of \u03b17 nicotinic acetylcholine receptor protects against 1-methyl-4-phenylpyridinium-induced astroglial apoptosis. Front Cell Neurosci. 2019;13:507.","journal-title":"Front Cell Neurosci."},{"issue":"22","key":"230_CR65","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/cells13221838","volume":"13","author":"M Mustafa","year":"2024","unstructured":"Mustafa M, Ahmad R, Tantry IQ, et al. Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications. Cells. 2024;13(22):1838.","journal-title":"Cells."},{"issue":"2","key":"230_CR66","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/ph14020149","volume":"14","author":"E Gajda","year":"2021","unstructured":"Gajda E, Grzanka M, Godlewska M, et al. The role of miRNA-7 in the biology of cancer and modulation of drug resistance. Pharmaceuticals (Basel). 2021;14(2):149.","journal-title":"Pharmaceuticals (Basel)."},{"issue":"5","key":"230_CR67","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/dna.2015.3097","volume":"35","author":"B Kong","year":"2016","unstructured":"Kong B, Wu PC, Chen L, et al. microRNA-7 protects against 1-methyl-4-phenylpyridinium iodide-induced cell apoptosis in SH-SY5Y cells by directly targeting Kr\u00fcpple-like factor 4. DNA Cell Biol. 2016;35(5):217\u2013225.","journal-title":"DNA Cell Biol."},{"issue":"10","key":"230_CR68","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.3390\/cells10102679","volume":"10","author":"KT Thomas","year":"2021","unstructured":"Thomas KT, Zakharenko SS. microRNAs in the onset of schizophrenia. Cells. 2021;10(10):2679.","journal-title":"Cells."},{"issue":"3","key":"230_CR69","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3349\/ymj.2018.59.3.416","volume":"59","author":"Y Song","year":"2018","unstructured":"Song Y, Liu Y, Chen X. miR-212 attenuates MPP\u207a-induced neuronal damage by targeting KLF4 in SH-SY5Y cells. Yonsei Med J. 2018;59(3):416\u2013424.","journal-title":"Yonsei Med J."},{"issue":"8","key":"230_CR70","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.4103\/NRR.NRR-D-24-00025","volume":"20","author":"R Song","year":"2025","unstructured":"Song R, Yin S, Wu J, et al. Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials. Neural Regen Res. 2025;20(8):2245\u20132263.","journal-title":"Neural Regen Res."},{"issue":"2","key":"230_CR71","first-page":"186","volume":"42","author":"Y Wang","year":"2026","unstructured":"Wang Y, Deng J, Tan J, et al. The mechanism of KLF4-mediated NF-\u03baB\/NLRP3 pathway regulating arteriovenous fistula dysfunction. Acta Cardiol Sin. 2026;42(2):186\u2013197.","journal-title":"Acta Cardiol Sin."},{"issue":"2","key":"230_CR72","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/biomedicines10020371","volume":"10","author":"NA Gouda","year":"2022","unstructured":"Gouda NA, Elkamhawy A, Cho J. Emerging therapeutic strategies for Parkinson\u2019s disease and future prospects: a 2021 update. Biomedicines. 2022;10(2):371.","journal-title":"Biomedicines."},{"issue":"7","key":"230_CR73","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/ph15070811","volume":"15","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yao L, Zheng Z, et al. The role of non-coding RNAs in the pathogenesis of Parkinson\u2019s disease: recent advancement. Pharmaceuticals (Basel). 2022;15(7):811.","journal-title":"Pharmaceuticals (Basel)."},{"issue":"5","key":"230_CR74","doi-asserted-by":"publisher","first-page":"219","DOI":"10.61186\/ibj.27.5.219","volume":"27","author":"S Ebrahimi","year":"2023","unstructured":"Ebrahimi S, Khosravi MA, Raz A, et al. CRISPR-cas technology as a revolutionary genome editing tool: mechanisms and biomedical applications. Iran Biomed J. 2023;27(5):219\u2013246.","journal-title":"Iran Biomed J."},{"key":"230_CR75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mrrev.2015.01.002","volume":"764","author":"H Shen","year":"2015","unstructured":"Shen H, McHale CM, Smith MT, et al. Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9. Mutat Res Rev Mutat Res. 2015;764:31\u201342.","journal-title":"Mutat Res Rev Mutat Res."},{"issue":"1","key":"230_CR76","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/biom10010137","volume":"10","author":"A Cianciulli","year":"2020","unstructured":"Cianciulli A, Porro C, Calvello R, et al. Microglia mediated neuroinflammation: focus on PI3K modulation. Biomolecules. 2020;10(1):137.","journal-title":"Biomolecules."},{"issue":"2","key":"230_CR77","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2012.08.082","volume":"527","author":"J Xi","year":"2012","unstructured":"Xi J, Zhang B, Luo F, et al. Quercetin protects neuroblastoma SH-SY5Y cells against oxidative stress by inhibiting expression of Kr\u00fcppel-like factor 4. Neurosci Lett. 2012;527(2):115\u2013120.","journal-title":"Neurosci Lett."},{"issue":"4","key":"230_CR78","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1007\/s12035-017-0584-5","volume":"55","author":"P Periyasamy","year":"2018","unstructured":"Periyasamy P, Liao K, Kook YH, et al. Cocaine-mediated downregulation of miR-124 activates microglia by targeting KLF4 and TLR4 signaling. Mol Neurobiol. 2018;55(4):3196\u20133210.","journal-title":"Mol Neurobiol."},{"issue":"12","key":"230_CR79","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/pharmaceutics12121216","volume":"12","author":"S Kimura","year":"2020","unstructured":"Kimura S, Harashima H. Current status and challenges associated with CNS-targeted gene delivery across the BBB. Pharmaceutics. 2020;12(12):1216.","journal-title":"Pharmaceutics."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00230-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-026-00230-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00230-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:10:34Z","timestamp":1787584234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-026-00230-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1007\/s11596-026-00230-8","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"1 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors assert that they do not have any known financial interests or personal relationships that could be perceived as influencing the work reported in this paper.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics Approval\u00a0and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}